1.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700, China; 2.School of Basic Medicine, Shanxi University of Chinese Medicine,Jinzhong 030600, China; 3.Pharmacy College of Minzu University of China, Beijing 100081, China
Abstract：To study of the main active components, targetsof Ginseng and Astragalusand theirmolecular mechanisms of cardiac or cerebral diseases by networkpharmacology.Based on the Integrative Pharmacology of Traditional Chinese Medicine(TCMIP), we have screened the components and target information of Ginseng and Astragalus, and carried out the related GO gene function and KEGG pathway enrichment analysis, andconstructed the core target network diagram and the "Traditional Chinese Medicine-ingredient-key drug target-pathway" network diagram.The 160common target of drugs,463 drug-diseasecore target informationof are screened from Ginseng and Astragalus hebral disease.Among the 463 drug-diseasecore target information, the 62 common targets, 131 potential drug targets and 25 known disease targets are mainly involved in multiple biological processes, such as mitochondrial energy production, transformation and oxidative metabolism. This study explains the similarities and differences of the effect and application onGinseng and Astragalus,which preliminarily revealthe mechanism of combinedaction that Ginseng and Astragalus in the treatment of cardio-cerebral diseases have the effect of Tonifying Qi,and it also provides a demonstration and reference for the in-depth study of the mechanism of the effect of traditional Chinese medicine.
周荣荣, 李志勇, 郭非非, 许海玉, 唐仕欢. 补气药人参、黄芪防治心脑疾病的网络药理学研究[J]. 复杂系统与复杂性科学, 2018, 15(1): 18-23.
ZHOU Rongrong,LI Zhiyong,GUO Feifei,XU Haiyu,TANG Shihuan. On the Network Pharmacology of Ginseng and Astragalus with Tonifying Qi to Prevent and Treatcardio-Cerebral Diseases. Complex Systems and Complexity Science, 2018, 15(1): 18-23.
[1]刘月, 初杰. 人参黄芪的性味与配伍对方剂构成的影响[J]. 辽宁中医药大学学报, 2008, 10(5):56. [2]贾蔷, 唐仕欢, 石作荣,等. 从中医气血理论探析“脑心同治”[J]. 世界中医药, 2014(10):12931295. [3]王冬菊.心脑血管疾病流行概况及主要影响因素[J].预防医学论坛,2016,22(01):7175. [4]郭优勤, 魏桂林, 钟秋明,等. 浅谈人参的临床应用[J]. 中国现代药物应用, 2011, 05(7):128129. [5]刘会艳. 黄芪及其制剂的药理作用和临床应用[J]. 内蒙古中医药, 2012, 31(22):4445. [6]许海玉, 刘振明, 付岩,等. 中药整合药理学计算平台的开发与应用[J]. 中国中药杂志,2017, 42(18):36333638. [7]Lipinski C A, Lombardo F, Dominy B W, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1[J]. Advanced Drug Delivery Reviews, 2001, 46(13):326. [8]Gaignard Pauline, Liere Philippe, Thérond Patrice, et al. Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases[J]. Frontiers in Aging Neuroscience, 2017, 9:406. [9]宋齐. 人参化学成分和药理作用研究进展[J]. 人参研究,2017, 29(2):4754. [10] 曹玉冰.黄芪甲苷的药理作用及其机制的研究进展[J].现代药物与临床,2017,32(05):954960. [11] Fernandes-Rosa F L, Boulkroun S, Zennaro M C. Somatic and inherited mutations in primary aldosteronism[J]. Journal of Molecular Endocrinology, 2017, 59(1):4763. [12] Hu H J, Song M. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.[J]. J Stroke Cerebrovasc Dis, 2017,26(12):27062719. [13] Nd D G, Vega R B, Kelly D P. Mitochondrial biogenesis and dynamics in the developing and diseased heart.[J]. Genes & Development, 2015, 29(19):19811991. [14] Fan X, Xie J, Tian J. Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target[J]. Cardiovasc Pharm Open Access, 2017, 6(1):112. [15] Heslegrave A J, Hussain K. Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase[J]. Journal of Clinical Endocrinology & Metabolism, 2013, 98(2):496. [16] Malik B, Fernandes C, Killick R, et al. Oligomeric amyloid-β peptide affects the expression of genes involved in steroid and lipid metabolism in primary neurons.[J]. Neurochemistry International, 2012, 61(3):321333. [17] Chen J, Young M E, Chatham J C, et al. TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling[J]. American Journal of Physiology Heart & Circulatory Physiology, 2016, 311(1):6475. [18] Adevaandany M M, Gonzálezlucán M, Donapetrygarcía C, et al. Glycogen metabolism in humans[J]. BBA Clinical, 2016, 5:85100. [19] Buervenich S, Carmine A, Galter D, et al. A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample.[J]. Archives of Neurology, 2005, 62(1):7478. [20] 韩学杰, 李成卫. 冠心病临床药对新用[M]. 中国医药科技出版社, 2005:369. [21] Nemmani K V S, Ramarao P. Ginseng total saponin potentiates acute U-50,488H-induced analgesia and inhibits tolerance to U-50,488H-induced analgesia in mice[J]. Pharmacology Biochemistry & Behavior, 2002, 72(12):16.
